1-119735394-C-T
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 1P and 13B. PP3BP4_StrongBP6BS1BS2
The NM_006623.4(PHGDH):c.743C>T(p.Ala248Val) variant causes a missense change. The variant allele was found at a frequency of 0.000238 in 1,614,098 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A248D) has been classified as Uncertain significance.
Frequency
Consequence
NM_006623.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PHGDH | NM_006623.4 | c.743C>T | p.Ala248Val | missense_variant | 7/12 | ENST00000641023.2 | NP_006614.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PHGDH | ENST00000641023.2 | c.743C>T | p.Ala248Val | missense_variant | 7/12 | NM_006623.4 | ENSP00000493175.1 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152232Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000412 AC: 103AN: 250070Hom.: 0 AF XY: 0.000429 AC XY: 58AN XY: 135254
GnomAD4 exome AF: 0.000246 AC: 359AN: 1461748Hom.: 2 Cov.: 32 AF XY: 0.000246 AC XY: 179AN XY: 727172
GnomAD4 genome AF: 0.000164 AC: 25AN: 152350Hom.: 0 Cov.: 33 AF XY: 0.000215 AC XY: 16AN XY: 74496
ClinVar
Submissions by phenotype
PHGDH deficiency Benign:3
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. - |
Likely benign, no assertion criteria provided | clinical testing | Natera, Inc. | Jan 07, 2020 | - - |
Neu-Laxova syndrome 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Intergen, Intergen Genetics and Rare Diseases Diagnosis Center | Sep 05, 2023 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Dec 15, 2024 | Reported previously as a likely pathogenic variant in a patient with West syndrome who also harbored a second variant (phase unknown) (PMID: 34055682); Reported previously as a maternally inherited heterozygous variant in a patient with CAKUT; however, no second variant was identified (PMID: 35711925); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 34055682, 35711925) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at